Skip to main content

Table 1 Clinical and biochemical characteristics by study group

From: Macrophage migration inhibitory factor promoter polymorphisms (−794 CATT5–8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects

 

Control group

(n = 186)

CHD group

(n = 70)

F/×2

P value

Mean age(year)a

60.78 ± 9.26

66.71 + 10.25

1.24

0.081

Ganderb

(male/female)

84/102

44/26

6.37

0.012

cigarette smoking(%)b

31.6%

33.3%

0.236

0.627

Drinking(%)b

18.3%

24.3%

0.677

0.41

Hypertension(%)b,c

66.7%

68.6%

0.054

0.817

Hyperlipidemia(%)b,d

16.7%

37.1%

6.76

0.009

Diabetes(%)b,e

3.3%

7.1%

0.92

0.337

  1. aData presented as mean ± SD. Student’s t-test
  2. bChi-square
  3. cblood pressure ≥ 140/90 mmHg
  4. dLDL-C ≥ 120mg/dl
  5. eFPG ≥ 7.0 mmol/l and/or OGTT 2 h FPG ≥ 11.1 mmol/l
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us